As Congress moves toward possible approval of a new prescription drug program for Medicare recipients later this summer, how payments for cancer drugs and therapeutic services are determined may well hang in the balance.
Is Your Texting as Caring as Your Bedside Manner?
The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice
Tax-Loss Harvesting: An Important Tactic Every Dermatologist Should Consider
Shanna Miranti, MPAS, PA-C, Shares Highlights From Diversity in Dermatology Meeting
Melanoma and the Wrong Site
Pre- and Postemployment Contract Review: Safeguard Your Interests